Deal date
KANDO id: 735431
Financial Transaction:
Series B
Mitra Biotech Pvt Ltd
Currency
United States Dollar
Value in original currency
27,400,000
Value in USD
27,400,000
Note
Funding to expand the availability of its CANScript service, which predicts personalised responses to cancer treatments. Part of the proceeds were used to cash out Series A backers Karnataka Information Technology Venture Capital Fund and India Innovation
Lead investor
| Investor | Country | Notes | |
|---|---|---|---|
|
Sands Capital Ventures LLC |
United States | |
|
Sequoia Capital India |
India |
Round participants
| Investor | Country | Notes | |
|---|---|---|---|
|
Accel Partners & Co IncEarly and growth stage venture capital firm. |
United States | Follow-on investment. |
|
RA Capital Management |
Initial investment. | |
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Tata Capital Innovations Fund |
India | Follow-on investment. |